You are browsing the archive for Sanofi - peHUB.

Sanofi Invests $125 Million in Warp Drive Bio

Posted on: January 10, 2012 by Connie LoizosNo Comments »

Boston-based Third Rock Ventures today launched the genomic search engine start-up, Warp Drive Bio, as part of a partnership with the French pharmaceutical company Sanofi. Sanofi is investing $125 million into the company, which Third Rock — an venture firm as well as incubator — has been developing for the last two years. PRESS RELEASE: [...]

peHUB First Read

Posted on: February 3, 2011 by Jonathan MarinoNo Comments »

At Long Last!: Sanofi-Genzyme could finally be happening

Growing: PepsiCo buys most of Russian dairy & juice company Wimm-Bill-Dann, plans full acquisition

Dealing:
Nelson Peltz might be orchestrating another deal for Wendy’s/Arby’s, instead of just splitting them up

What’s in a Name?
: Groupon is reportedly trying to buy Hipster

Sanofi-Aventis Buying Fovea Pharma for €370 Million

Posted on: October 1, 2009 by PEHub AdministratorNo Comments »

Sanofi-Aventis has agreed to acquire Fovea Pharmaceuticals SA, a Paris, France-based drug company focused on ophthalmic diseases. The deal is valued at up to €370 million, including an upfront payment and possible milestone payments. Fovea had raised over $60 million in VC funding from firms like Forbion Capital Partners, Sofinnova Partners, Abingworth, GIMV, The Wellcome Trust and CAPE.

Sanofi Paying Up to $500 Million for BiPar Sciences

Posted on: April 15, 2009 by PEHub AdministratorNo Comments »

Sanofi-aventis (NYSE: SNY) has agreed to acquire BiPar Sciences Inc., a Brisbane, Calif.-based developer of PARP inhibitors as cancer therapies. The deal could be worth up to $500 million, based on the achievement of milestones for BiPar’s lead candidate. BiPar has raised around $60 million in VC funding, from firms like Domain Associates, Canaan Partners, Vulcan Capital, PolyTechnos Venture-Partners, Asset Management Company and Quantum Technology Partners. It also has raised venture debt from Lighthouse Capital Partners.